Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trial
Titel:
Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trial
Auteur:
Eustace, Amanda Irlam, Joely J. Taylor, Janet Denley, Helen Agrawal, Shailesh Choudhury, Ananya Ryder, David Ord, Jonathan J. Harris, Adrian L. Rojas, Ana M. Hoskin, Peter J. West, Catharine M.L.